PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
68.10
-0.04 (-0.06%)
At close: May 17, 2024, 4:00 PM
67.49
-0.61 (-0.90%)
After-hours: May 17, 2024, 6:49 PM EDT
PROCEPT BioRobotics Market Cap
PROCEPT BioRobotics has a market cap or net worth of $3.50 billion as of May 17, 2024. Its market cap has increased by 163.78% in one year.
Market Cap
3.50B
Enterprise Value
3.36B
1-Year Change
163.78%
Ranking
Category
Stock Price
$68.10
Market Cap Chart
Since the IPO on September 15, 2021, PROCEPT BioRobotics's market cap has increased from $1.06B to $3.50B, an increase of 231.49%. That is a compound annual growth rate of 56.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 3.50B | -0.06% |
May 16, 2024 | 3.50B | -1.52% |
May 15, 2024 | 3.56B | 5.94% |
May 14, 2024 | 3.36B | 2.85% |
May 13, 2024 | 3.27B | 1.36% |
May 10, 2024 | 3.22B | -0.56% |
May 9, 2024 | 3.24B | 4.37% |
May 8, 2024 | 3.10B | -3.87% |
May 7, 2024 | 3.23B | 2.21% |
May 6, 2024 | 3.16B | -4.48% |
May 3, 2024 | 3.31B | 4.16% |
May 2, 2024 | 3.17B | 2.78% |
May 1, 2024 | 3.09B | 14.40% |
Apr 30, 2024 | 2.70B | 1.79% |
Apr 29, 2024 | 2.65B | 0.42% |
Apr 26, 2024 | 2.64B | -0.86% |
Apr 25, 2024 | 2.66B | -0.38% |
Apr 24, 2024 | 2.67B | -2.36% |
Apr 23, 2024 | 2.74B | 5.00% |
Apr 22, 2024 | 2.61B | 1.99% |
Apr 19, 2024 | 2.56B | -1.74% |
Apr 18, 2024 | 2.60B | -1.37% |
Apr 17, 2024 | 2.64B | -0.38% |
Apr 16, 2024 | 2.65B | 2.75% |
Apr 15, 2024 | 2.58B | -0.22% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Insmed | 3.72B |
Axsome Therapeutics | 3.67B |
HUTCHMED (China) | 3.65B |
Alvotech | 3.60B |
Ultragenyx Pharmaceutical | 3.54B |
Axonics | 3.45B |
LivaNova | 3.42B |
Biohaven Pharmaceutical Holding Company | 3.41B |